Enovis (ENOV)
(Delayed Data from NYSE)
$45.40 USD
-1.14 (-2.45%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $45.43 +0.03 (0.07%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth D Momentum C VGM
Price, Consensus and EPS Surprise
ENOV 45.40 -1.14(-2.45%)
Will ENOV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ENOV based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ENOV
Standard BioTools (LAB) Reports Q2 Loss, Misses Revenue Estimates
Analysts Estimate Enovis (ENOV) to Report a Decline in Earnings: What to Look Out for
ENOV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should You Buy Hims & Hers (HIMS) Stock Ahead of Q2 Earnings?
Select Medical's (SEM) Unit Begins IPO Roadshow for 22.5M Shares
Zacks.com featured highlights include Energizer, Super League Enterprise and Enovis
Other News for ENOV
Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
Enovis to Host Second Quarter 2024 Results Conference Call on August 7th
Enovis? Releases AltiVate Reverse? Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse?
Top 3 Health Care Stocks That Could Blast Off In June
August 16th Options Now Available For Enovis (ENOV)